Our History

We are Diffucap-Chemobras Química Farmacêutica Ltda., a company with over 50 years of tradition in the pharmaceutical market. Located in Rio de Janeiro, we are certified by ANVISA with Good Manufacturing Practices (GMP), which allows us to produce solid oral medications, including those subject to special control under Ordinance 344/98, across various therapeutic classes.

Galeria

No data was found
#SouDiffucapRoxo

Our Values

Results Through Numbers

We believe that numbers speak for themselves. We rely on concrete data to guide our decisions, support our ideas, and turn information into strategic action. Where words hesitate, data brings clarity.

Looking to the Future

We are always one step ahead. We anticipate challenges and needs—our own and our team’s—to save time, increase efficiency, and build lasting solutions.

Problem Sheriff

Problems don’t belong to departments—they have owners. When something isn’t right, we act. We take responsibility with courage and initiative because no one here stands by with folded arms.

Pride in Belonging

We are Brazilian and have empathy in our DNA. We care for every person with attention and generosity, without losing the firmness of those who feel the business is also their own. Wherever there is a need, there will be someone from our team—with excellence and heart.

Products

ANGIOPRIL
Enalapril Maleate 10 mg

Antihypertensive

with 30 tablets
  • Accessibility treatment
  • Hypertension of all stages

ARFLEX RETARD
nimesulide 200mg

Anti-inflammatory

with 6 or 12 capsules
  • Single daily dose
  • Prolonged-release microgranules
  • Fewer side effects

ARTRODIFF PLUS
Dietary Supplement in Capsules

with 60 capsules
  • Exclusive Blend
  • Multi-target action
  • 6-in-1

DEOCIL SL
ketorolac tromethamine 10 mg

Analgesic

with 10, 20, or 30 sublingual tablets
  • Fast action
  • High analgesic potency
  • Non-sedating

FLUXTAR SR
bromazepam 3mg and 6mg

Standard Anxiolytic

with 30 capsules
  • SLP Technology
  • Reduces anxiety
  • Reduces tension symptoms

LONCORD RETARD
Nifedipine 20mg and 40mg

Antianginal and Vasodilator

with 20 or 30 capsules
  • Reduces cardiovascular events by up to 50%
  • Prolonged-release microgranules

Work With Us

At Diffucap, every talent is an essential part of our journey. Together, we drive health solutions and expand our results.

Innovative Technology

Microgranules

Extended Release System (ERS)

One of our main differentiators is the Extended Release System (ERS), which enables the creation of long-acting and highly effective medications. This innovative technology allows for adjustments in dosage and concentration, ensuring greater treatment efficacy while minimizing side effects.

Become Our Partner

We are looking for new partners in laboratories and industries. Would you like to outsource your production with quality and efficiency?

Learn About the Program

With DiffuCare, you gain access to a wide range of essential medications!

Nossos produtos
mais perto de você

Digite seu CEP e encontre uma farmárcia parceira mais próxima a você!

Blog Diffucap

Knowledge and Innovation in Health

Follow the latest news in the pharmaceutical industry, health tips, technological innovations, and insights from our specialists.

Featured Posts

Osteoarthritis is a chronic joint condition that causes cartilage wear, pain, stiffness, and limited movement. Modern joint care combines professional monitoring, healthy lifestyle habits, and science-based support strategies. With a focus on innovation and an exclusive formulation, Diffucap developed ARTRODIFF PLUS®, designed to support joint health and mobility. What is osteoarthritis and what are the […]

Diffucap introduces its new packaging designed to enhance safety, accessibility and the overall patient experience. Key improvements include high contrast, larger typography, LIBRAS accessibility markers and a modern visual identity. The update reinforces the brand’s commitment to innovation and patient-centered care.
Diffucap celebrated its 50th anniversary with strong presence at the 57th CBOT 2025, unveiling its new packaging identity and launching Artrodiff Plus. The participation reinforces the company’s commitment to innovation, joint health, and the advancement of orthopedics in Brazil.
Diffucap celebrates its 50th anniversary with a rebranding and appoints Martin Gold as its new president. With experience at SolarMente, Metyis, and Techint, he steps in with a focus on innovation and brand identity strengthening.
Diffucap celebrates its 50th anniversary with a complete rebranding, new positioning, and a new president. The company introduces a modern visual identity, more accessible packaging, and prepares to enter the OTC market. Under Martin Gold’s leadership, the strategic shift was celebrated at Christ the Redeemer, illuminated in purple.
Nimesulide is an effective anti-inflammatory drug but may cause gastrointestinal, liver, skin, and cardiovascular side effects. Reading the leaflet and consulting a doctor is essential for safe use. Artflex Retard is a reliable nimesulide-based option for pain and inflammation relief.

Pharmacovigilance

Adverse event? Click the button below and fill out the form, or contact us at 0800 282 9800 / sac@diffucap.com.br

Contact Us